- Issuer ticker
-
PNTG
- Reported as of
-
06 Aug 2026
- Net transaction value
-
-$53,700
- SEC form
-
4
- Accepted by SEC
-
10 Aug 2026, 15:48:46 UTC
Filing notes and source
Key filing fact
Jason Paul Steik filed Form 4 for Pennant Group, Inc. (PNTG) on 10 Aug 2026.
Key facts
- This page summarizes Jason Paul Steik's Form 4 filing for Pennant Group, Inc. (PNTG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Aug 2026, 15:48.
Change
- Previous filing in this sequence was filed on 12 Mar 2026.
- Current net transaction value: -$53,700.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002078374
Primary reporting owner
Steik Jason Paul
- Relationship
-
Chief Clinical Officer
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PNTG
transaction
Common Stock
Sale
- Transaction value
- -$53,700
- Shares
- -1,394
- Change %
- -8.4%
- Price
-
$38.52
- Shares after
- 15,106
- Date
- 06 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).